IRAK4 and myelodysplastic syndrome: PD-1H, a protein expressed by hematopoietic cells that acts as a homolog of PD-1 or PD-L1, and IRAK4, which is elevated in MDS patients with splicing factor mutations, are also potential immunological targets (69).